The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphos...
שמור ב:
| הוצא לאור ב: | Breast Cancer Res |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2001
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138714/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11879558/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr415 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|